What is the recommended dose of Diflucan (fluconazole) for an uncomplicated yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diflucan Dose for Yeast Infection

For uncomplicated vaginal yeast infections, take a single 150 mg oral dose of fluconazole (Diflucan). This achieves clinical cure rates of 92-99% and is the standard first-line treatment recommended by both the Infectious Diseases Society of America and the American College of Obstetricians and Gynecologists 1, 2, 3, 4.

Uncomplicated vs. Complicated Disease

Uncomplicated vulvovaginal candidiasis includes:

  • Mild-to-moderate symptoms 3
  • Sporadic, non-recurrent episodes 3
  • Normal immune function 3
  • Infection caused by Candida albicans (which accounts for 83-92% of cases) 3, 5

For severe acute disease, the dosing changes significantly:

  • Fluconazole 150 mg every 72 hours for a total of 2-3 doses 1, 2, 3
  • This multi-dose regimen achieves significantly higher clinical cure rates compared to single-dose therapy in severe cases (P = 0.015 at day 14) 5
  • Severe disease is characterized by extensive vulvar erythema, edema, excoriation, and fissure formation 1

Recurrent Infections

For recurrent vulvovaginal candidiasis (defined as 4 or more episodes per year):

  • Initial induction therapy: Oral fluconazole or topical agent for 10-14 days 1, 3
  • Maintenance therapy: Fluconazole 150 mg weekly for 6 months 1, 2, 3
  • This regimen keeps 90.8% of women disease-free at 6 months 2

Non-albicans Species

For C. glabrata infections unresponsive to oral azoles:

  • First-line alternative: Topical intravaginal boric acid 600 mg daily in gelatin capsules for 14 days 1, 2
  • Second-line: Nystatin intravaginal suppositories 100,000 units daily for 14 days 1
  • Non-albicans Candida species predict significantly reduced response to fluconazole regardless of treatment duration 5

Common Pitfalls

  • Do not treat empirically without confirmation: Approximately 10-20% of women harbor Candida asymptomatically, and symptoms are nonspecific 1, 3
  • Confirm diagnosis with wet mount preparation using saline and 10% potassium hydroxide to demonstrate yeast or hyphae before treatment 2
  • Check vaginal pH: Normal pH (4.0-4.5) is typical with candida infections; elevated pH suggests bacterial vaginosis or trichomoniasis instead 2
  • Inadequate treatment duration may lead to recurrence of active infection 4

Safety and Tolerability

Fluconazole is well tolerated with minimal side effects:

  • Mild gastrointestinal complaints are the most common adverse effects 6
  • Serious adverse effects are rare 5
  • The single 150 mg dose has excellent bioavailability (>93%) and achieves therapeutic concentrations rapidly 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fluconazole Dosing for Vaginal Candidiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluconazole Treatment for Uncomplicated Vulvovaginal Candidiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.